BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20106868)

  • 21. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
    Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
    Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WT1 expression alters tumorigenicity of the G401 kidney-derived cell line.
    McMaster ML; Gessler M; Stanbridge EJ; Weissman BE
    Cell Growth Differ; 1995 Dec; 6(12):1609-17. PubMed ID: 9019166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotype/phenotype correlations in Wilms' tumor.
    Huff V
    Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline mutations of the POU6F2 gene in Wilms tumors with loss of heterozygosity on chromosome 7p14.
    Perotti D; De Vecchi G; Testi MA; Lualdi E; Modena P; Mondini P; Ravagnani F; Collini P; Di Renzo F; Spreafico F; Terenziani M; Sozzi G; Fossati-Bellani F; Radice P
    Hum Mutat; 2004 Nov; 24(5):400-7. PubMed ID: 15459955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coordinate expression of Wilms' tumor genes correlates with Wilms' tumor phenotypes.
    Yeger H; Cullinane C; Flenniken A; Chilton-MacNeil S; Campbell C; Huang A; Bonetta L; Coppes MJ; Thorner P; Williams BR
    Cell Growth Differ; 1992 Dec; 3(12):855-64. PubMed ID: 1335280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
    Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
    J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning of the nucleostemin gene and its function in transforming human embryonic bone marrow mesenchymal stem cells into F6 tumor cells.
    Han C; Zhang X; Xu W; Wang W; Qian H; Chen Y
    Int J Mol Med; 2005 Aug; 16(2):205-13. PubMed ID: 16012751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak.
    Morrison DJ; English MA; Licht JD
    Cancer Res; 2005 Sep; 65(18):8174-82. PubMed ID: 16166292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts.
    Hosono S; Luo X; Hyink DP; Schnapp LM; Wilson PD; Burrow CR; Reddy JC; Atweh GF; Licht JD
    Oncogene; 1999 Jan; 18(2):417-27. PubMed ID: 9927198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WT1: a novel tumor suppressor gene inactivated in Wilms' tumor.
    Haber DA; Buckler AJ
    New Biol; 1992 Feb; 4(2):97-106. PubMed ID: 1313285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells.
    Boland GM; Perkins G; Hall DJ; Tuan RS
    J Cell Biochem; 2004 Dec; 93(6):1210-30. PubMed ID: 15486964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pax-2, kidney development, and oncogenesis.
    Dressler GR
    Med Pediatr Oncol; 1996 Nov; 27(5):440-4. PubMed ID: 8827071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
    Pritchard-Jones K; Fleming S
    Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors.
    Li CM; Kim CE; Margolin AA; Guo M; Zhu J; Mason JM; Hensle TW; Murty VV; Grundy PE; Fearon ER; D'Agati V; Licht JD; Tycko B
    Am J Pathol; 2004 Dec; 165(6):1943-53. PubMed ID: 15579438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue.
    Shih DT; Lee DC; Chen SC; Tsai RY; Huang CT; Tsai CC; Shen EY; Chiu WT
    Stem Cells; 2005 Aug; 23(7):1012-20. PubMed ID: 15941858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional interleukin-7/interleukin-7Ralpha, and SDF-1alpha/CXCR4 are expressed by human periodontal ligament derived mesenchymal stem cells.
    Trubiani O; Isgro A; Zini N; Antonucci I; Aiuti F; Di Primio R; Nanci A; Caputi S; Paganelli R
    J Cell Physiol; 2008 Mar; 214(3):706-13. PubMed ID: 17894415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies.
    Fukuzawa R; Heathcott RW; More HE; Reeve AE
    J Clin Pathol; 2007 Sep; 60(9):1013-6. PubMed ID: 17172473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
    Park S; Tomlinson G; Nisen P; Haber DA
    Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
    Scharnhorst V; Kranenburg O; van der Eb AJ; Jochemsen AG
    Cell Growth Differ; 1997 Feb; 8(2):133-43. PubMed ID: 9040935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.